Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARMIC: Trabectedin Combined With Metronomic Cyclophosphamide in Advanced Soft-tissue Sarcomas
NCT02805725Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Dec 2015
- Primary completion
- Apr 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in soft tissue sarcoma (STS), sponsored by Institut Bergonié. Started Dec 2015; status: completed.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02805725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805725.